Fengyuan Pharmaceutical Co., Ltd.
丰原药业
000153
Shenzhen Stock Exchange
Key Financials
As of 2026-05-23T00:00:00.000+00:00Announcements
Announcement on Holding the 2025 Annual Performance Presentation
Announcement on the Approval Notice for the Listing Application of Fumaric Acid Vonoprazan Chemical Raw Materials by Wholly-Owned Subsidiary
Announcement on Obtaining Drug Registration Certificate
Announcement on the Reappointment of Audit Institutions for the Year 2026
Independent Director 2025 Annual Work Report (Zhang Ruiwen)
Independent Director 2025 Annual Work Report (Wu Cisheng)
Fengyuan Pharmaceutical 2025 Internal Control Audit Report
Board's Special Explanation on Matters Involved in the Unqualified Opinion Internal Control Audit Report for the Year 2025 with Emphasis on Matters
Internal Control Self-Evaluation Report
Management Measures to Prevent Controlling Shareholders and Related Parties from Occupying Company Funds
Director and Senior Management Compensation Management System
General Manager Work Rules
Temporary Suspension and Exemption Management System for Information Disclosure
Senior Management Compensation Plan
Director Compensation Plan
Announcement on Expected Daily Related Transactions for the Year 2026
Announcement on Providing Guarantees for Working Capital Loans of Wholly-Owned Subsidiaries
Notice of the 2025 Annual Shareholders' Meeting
Board Resolution Announcement
Announcement on the Provision for Impairment for the Year 2025
Announcement on the Company's Profit Distribution Plan for the Year 2025
2026 First Quarter Report
Board's Report on the Performance of the Accounting Firm and the Audit Committee
Special Explanation on Non-Operating Fund Occupation and Other Related Fund Transactions for the Year 2025
Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for the Year 2025
Board's Special Opinion on the Self-Examination of Independent Directors' Independence
2025 Annual Audit Report
2025 Annual Report
2025 Annual Report Summary
Special Report on the Cancellation of Illegal Guarantees and the Repayment of Non-Operating Fund Occupation by Related Parties of Anhui Fengyuan Pharmaceutical Co., Ltd. for the Year 2025 and Beyond
Notes & Comments
Sign in to leave a comment or private note.
Loading…